Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
  Overview | AN2690 | AN2718 | AN2728 | AN2898 | Systemic Antibiotics | Neglected Diseases | Clinical Trials
  Pipeline

We sponsor clinical trials that are designed to determine the safety and efficacy of our drug candidates.

Learn more about our current pipeline.

To learn more about the Anacor clinical trials that are under way or to find out if a study is enrolling patients in your area, please visit www.clinicaltrials.gov.





We believe the unique characteristics of boron allow us to engineer novel product candidates that target a broad range of diseases and drive a rapid and efficient drug development process. AN2690